Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|July 2, 2020
Late-onset MADD: a rare cause of cirrhosis and acute liver failure?Patrick Soldath, Allan Lund, John VissingJIMD Reports|May 12, 2021
Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasiaOlivia Sarah Strandbech, Allan Lund, Elsebet OstergaardJIMD Reports|November 5, 2014
Mild Lesch-Nyhan Disease in a Boy with a Null Mutation in HPRT1: An Exception to the Known Genotype-Phenotype CorrelationAllan Bayat, Mette Christensen, Flemming Wibrand, et al.Ugeskrift for Laeger|April 8, 2021
[Hyperammonaemic encephalopathy in adults without liver diseases]Thomas Kromann Nøhr, Peter Lykke Eriksen, Allan Lund, et al.Ophthalmic Genetics|June 25, 2021
Genetic disease is a common cause of bilateral childhood cataract in DenmarkLine Kessel, Daniella Bach-Holm, Moug Al-Bakri, et al.Acta Paediatrica (Oslo, Norway : 1992)|March 10, 2023
High yield on aetiology using a systematic diagnostic approach to paediatric acute liver failure, analysis of a nationwide cohortThilde Nordmann Winther, Alex Yde Nielsen, Allan Lund, et al.Scientific Reports|September 28, 2019
Cardiac function and incidence of unexplained myocardial scarring in patients with primary carnitine deficiency - a cardiac magnetic resonance studyKasper Kyhl, Tóra Róin, Allan Lund, et al.Journal of Inherited Metabolic Disease|October 9, 2024
Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosisNathalie Guffon, Line Borgwardt, Anna Tylki-Szymańska, et al.Metabolomics : Official Journal of the Metabolomic Society|July 27, 2025
A diagnostic algorithm for inherited metabolic disorders using untargeted metabolomicsQian Gao, Adnan Khan, Mette Christensen, et al.Molecular Genetics and Metabolism|May 3, 2018
Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosisPaul Harmatz, Federica Cattaneo, Diego Ardigò, et al.Pageof 2